Physician profile
Roy D Loewenstein
NPI 1295793941
$1,221.79
in general payments reported to CMS, 2019-2025
21 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $17.16 · 2022: $210 · 2023: $401 · 2024: $149 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $154.56 | 2023-2025 | Shingrix, Arexvy |
| Sanofi Pasteur INC. | $146.26 | 2019-2025 | |
| Pfizer INC. | $129.68 | 2019-2025 | |
| Abbott Laboratories | $123.84 | 2022-2023 | Freestyle Libre 3 |
| Amgen INC. | $112.40 | 2019-2025 | Evenity, Prolia |
| Merck Sharp & Dohme LLC | $73.85 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Novartis Pharmaceuticals Corporation | $68.26 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $53.94 | 2022-2023 | |
| Medtronic Vascular, INC. | $48.48 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.79 | 2022 | |
| Xeris Pharmaceuticals, INC. | $42.25 | 2023 | Gvoke Hypopen, Recorlev |
| Nestle Healthcare Nutrition INC. | $35.28 | 2023 | |
| Abbvie INC. | $30.08 | 2023 | |
| Insulet Corporation | $28.69 | 2022 | |
| Novo Nordisk INC | $27.89 | 2024-2025 | Rybelsus, Ozempic |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $23.40 | 2022 | |
| Lilly USA, LLC | $19.92 | 2023 | Mounjaro |
| Exact Sciences Corporation | $16.79 | 2023 | Cologuard Collection Kit |
| Nevro Corp. | $16.39 | 2019 | |
| Covidien LP | $15.47 | 2019 | |
| Tandem Diabetes Care, INC. | $11.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Loewenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.